Adena Health announced on Sept. 1, 2026 that it had acquired Fairfield Medical Center, a hospital system in southeastern Ohio, the Federal Trade Commission said in a statement issued the following day.
The announcement followed an FTC investigation of an earlier attempt by a different acquirer, OhioHealth, to buy Fairfield Medical Center, according to the commission. That proposed transaction was abandoned.
What the agency said its staff found
The commission said staff’s investigation of the OhioHealth transaction “raised serious competitive concerns,” stating that the proposed deal “risked raising costs and reducing the quality of care for Ohioans.” The investigation also raised concerns about the thoroughness of Fairfield Medical Center’s process for identifying potential buyers, the agency said.
FTC staff coordinated with the Ohio Attorney General’s Office throughout the investigation, according to the statement.
The commission said staff encouraged Fairfield Medical Center to seek alternative buyers through what it described as a robust sales process. That process attracted interest from multiple potential buyers and resulted in the abandonment of the OhioHealth transaction and the partnership with Adena Health, the agency said.
The FTC did not file a complaint in the matter, and the statement does not disclose the terms of either the abandoned or the completed transaction.
The failing firm argument
Daniel Guarnera, director of the FTC’s Bureau of Competition, framed the outcome as a warning to companies that seek to justify a merger on the ground that one party would otherwise exit the market — an argument known in antitrust practice as the failing firm defense.
“The Commission remains vigilant in preserving healthcare competition, especially when reviewing deals involving hospitals that serve rural communities,” Guarnera said in the statement. “Today’s announcement should serve as a reminder that we will stop bad hospital deals. This matter should also serve as a reminder to firms, including hospitals, that might wish to make a failing firm argument. The standard is demanding, and if you have not searched broadly for a buyer, we will work expeditiously with firms to investigate whether there is a better buyer and, if the Commission deems it necessary, go to court to block a bad deal.”
He added: “I’m pleased that staff’s dedicated work resulted in a better deal for the people of Ohio without the need to resort to litigation. This is a win for the Commission, for FMC, and, most importantly for FMC’s patients and employees.”
Separate statement on buyer searches
In response to the completed Adena Health acquisition, Chairman Andrew N. Ferguson issued a separate statement, joined by Commissioner Mark R. Meador, regarding best practices for firms when they shop for a buyer, the commission said. The contents of that statement are not reproduced in the press release.
The commission said the Adena Health partnership will allow Fairfield Medical Center to continue serving patients in Ohio over the long term “without the competitive risks posed by the previously proposed OhioHealth deal.”
Source: Federal Trade Commission, “Statement Regarding Fairfield Medical Center’s Sale to Adena Health,” released September 2, 2026. The document describes conclusions reached by commission staff during a non-public investigation; no complaint or court filing is referenced, and the release does not state the financial terms of either transaction.